Truist Securities Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $60

Axogen, Inc.

Axogen, Inc.

AXGN

0.00

Truist Securities analyst Ravi Misra initiates coverage on Axogen (NASDAQ: AXGN) with a Buy rating and announces Price Target of $60.